Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerwin Huls

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
International Journal of Molecular Sciences|March 3, 2021
Inhibition of Autophagy Does Not Re-Sensitize Acute Myeloid Leukemia Cells Resistant to CytarabineNienke Visser, Harm Jan Lourens, Gerwin Huls, et al.
British Journal of Haematology|July 20, 2016
Overexpression of TP53 is associated with poor survival, but not with reduced response to hypomethylating agents in older patients with acute myeloid leukaemiaLieke H van der Helm, Gerbrig Berger, Arjan Diepstra, et al.
Clinical and Translational Medicine|October 17, 2023
Evolution of clonal hematopoiesisIsabelle A van Zeventer, Aniek O de Graaf, Joop H Jansen, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 24, 2012
[Calcium suppletion for patients who use gastric acid inhibitors: calcium citrate or calcium carbonate?]H J M Henk-Marijn de Jonge, R O B Rijk Gans, Gerwin Huls
Cancers|July 9, 2022
The Novel Immune Checkpoint GPR56 Is Expressed on Tumor-Infiltrating Lymphocytes and Selectively Upregulated upon TCR SignalingVrouyr Bilemjian, Martijn R Vlaming, Jimena Álvarez Freile, et al.
Bone Marrow Transplantation|March 20, 2025
Donor lymphocyte infusions after HLA-identical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in acute myeloid leukemia patientsTatum N Storck, Linde M Morsink, Anouschka Biswana, et al.
Aging|February 17, 2010
Paradoxical down-regulation of p16 mRNA with advancing age in acute myeloid leukemiaHendrik J M de Jonge, Carolien M Woolthuis, Eveline S J M de Bont, et al.
Immunologic Research|June 25, 2025
High expression of signal regulatory protein beta 2 marks a favourable prognostic AML subgroup and associates with increased sensitivity to phagocytosisNienke Visser, Nisha K van der Meer, Yuan He, et al.
Frontiers in Immunology|August 10, 2023
A luminescence-based method to assess antigen presentation and antigen-specific T cell responses for <i>in vitro</i> screening of immunomodulatory checkpoints and therapeuticsJimena Álvarez Freile, Yuzhu Qi, Lisa Jacob, et al.
Haematologica|October 30, 2020
The IL1-IL1RAP axis plays an important role in the inflammatory leukemic niche that favors acute myeloid leukemia proliferation over normal hematopoiesisBauke De Boer, Sofia Sheveleva, Katja Apelt, et al.
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
International Journal of Molecular Sciences|March 3, 2021
Inhibition of Autophagy Does Not Re-Sensitize Acute Myeloid Leukemia Cells Resistant to CytarabineNienke Visser, Harm Jan Lourens, Gerwin Huls, et al.
British Journal of Haematology|July 20, 2016
Overexpression of TP53 is associated with poor survival, but not with reduced response to hypomethylating agents in older patients with acute myeloid leukaemiaLieke H van der Helm, Gerbrig Berger, Arjan Diepstra, et al.
Clinical and Translational Medicine|October 17, 2023
Evolution of clonal hematopoiesisIsabelle A van Zeventer, Aniek O de Graaf, Joop H Jansen, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 24, 2012
[Calcium suppletion for patients who use gastric acid inhibitors: calcium citrate or calcium carbonate?]H J M Henk-Marijn de Jonge, R O B Rijk Gans, Gerwin Huls
Cancers|July 9, 2022
The Novel Immune Checkpoint GPR56 Is Expressed on Tumor-Infiltrating Lymphocytes and Selectively Upregulated upon TCR SignalingVrouyr Bilemjian, Martijn R Vlaming, Jimena Álvarez Freile, et al.
Bone Marrow Transplantation|March 20, 2025
Donor lymphocyte infusions after HLA-identical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in acute myeloid leukemia patientsTatum N Storck, Linde M Morsink, Anouschka Biswana, et al.
Aging|February 17, 2010
Paradoxical down-regulation of p16 mRNA with advancing age in acute myeloid leukemiaHendrik J M de Jonge, Carolien M Woolthuis, Eveline S J M de Bont, et al.
Immunologic Research|June 25, 2025
High expression of signal regulatory protein beta 2 marks a favourable prognostic AML subgroup and associates with increased sensitivity to phagocytosisNienke Visser, Nisha K van der Meer, Yuan He, et al.
Frontiers in Immunology|August 10, 2023
A luminescence-based method to assess antigen presentation and antigen-specific T cell responses for <i>in vitro</i> screening of immunomodulatory checkpoints and therapeuticsJimena Álvarez Freile, Yuzhu Qi, Lisa Jacob, et al.
Haematologica|October 30, 2020
The IL1-IL1RAP axis plays an important role in the inflammatory leukemic niche that favors acute myeloid leukemia proliferation over normal hematopoiesisBauke De Boer, Sofia Sheveleva, Katja Apelt, et al.
Pageof 17